Picture of Zynerba Pharmaceuticals logo

ZYNE — Zynerba Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall Cap

Brief: Zynerba Pharmaceuticals Enters Into Equity Purchase Agreement For Up To $20 Million With Lincoln Park Capital

July 21 (Reuters) - Zynerba Pharmaceuticals Inc  ZYNE.O :
    * ZYNERBA PHARMACEUTICALS ENTERS INTO EQUITY PURCHASE
AGREEMENT FOR UP TO $20 MILLION WITH LINCOLN PARK CAPITAL
    * ZYNERBA PHARMACEUTICALS -  CO TO HAVE RIGHT TO SELL TO LPC
UP TO
$20 MILLION WORTH OF SHARES OVER 36-MONTH TERM OF AGREEMENT

Source text for Eikon:  ID:nGNX8dZyJQ 
Further company coverage:  ZYNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zynerba Pharmaceuticals

See all news